HEIDELBERG, GERMANY / ACCESSWIRE / September 23, 2022 / After seven years of development work, Precisis GmbH, headquartered in Heidelberg, has received the CE certification for its minimally invasive ...
A neurostimulation device developed to treat focal epilepsy has received breakthrough device designation from the FDA. Precisis AG’s Easee [Epicranial Application of Stimulation Electrodes] minimally ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback